AlphaCentric Advisors’s MyoKardia MYOK Stock Holding History
Bought
Maintained
Sold
AlphaCentric Advisors's MYOK Position: Q4 2020 in Review
AlphaCentric Advisors sold out of MyoKardia (MYOK) in Q4 2020, closing a stake of 175 shares — an estimated $24K sold.
AlphaCentric Advisors first reported a position in MYOK in Q3 2020 and held it in 1 quarter. The position peaked at $24K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- AlphaCentric Advisors reported no remaining MyoKardia position as of Q4 2020 after selling out during the quarter.
- AlphaCentric Advisors sold 175 MyoKardia shares in Q4 2020, an estimated $24K.
- AlphaCentric Advisors first reported a position in MyoKardia in Q3 2020 and held it in 1 quarter.
- AlphaCentric Advisors's MyoKardia position peaked at $24K in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia as of Q4 2020.
Based on AlphaCentric Advisors's 13F filing for Q4 2020, filed 11 Mar 2022.